Stout Stephen 4
4 · Shattuck Labs, Inc. · Filed Mar 8, 2024
Insider Transaction Report
Form 4
Stout Stephen
See Remarks
Transactions
- Sale
Common Stock
2024-03-06$10.53/sh−4,650$48,965→ 79,332 total - Sale
Common Stock
2024-03-06$10.53/sh−4,895$51,544→ 74,437 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-06−6,459→ 17,391 totalExercise: $3.57Exp: 2033-01-25→ Common Stock (6,459 underlying) - Sale
Common Stock
2024-03-06$10.53/sh−6,459$68,013→ 79,332 total - Exercise/Conversion
Common Stock
2024-03-06$3.51/sh+4,650$16,321→ 83,982 total - Exercise/Conversion
Common Stock
2024-03-06$3.57/sh+6,459$23,059→ 85,791 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-06−4,650→ 9,300 totalExercise: $3.51Exp: 2032-09-08→ Common Stock (4,650 underlying)
Footnotes (3)
- [F1]Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023.
- [F2]The stock option was granted to the Reporting Person on September 8, 2022, one-third of which vested on September 8, 2023 and the remaining two-thirds of which will vest on September 8, 2024.
- [F3]The stock option was granted to the Reporting Person on January 25, 2023, one-quarter of which vested on January 10, 2024 and the remaining three-quarters of which will vest in approximately equal monthly installments through January 10, 2027.